Abbott receives FDA approval for minimally invasive Portico with FlexNav TAVR system to treat patients with aortic valve disease
September 20, 2021 – Abbott (Abbott Park, IL) announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Portico with FlexNav transcatheter…